To demonstrate that the overexpression of TGF-β generated in the allergic airway inflammation model was partially responsible for the increased apoptosis and the inhibition in cell proliferation that resulted in the inhibition of tumor progression, we performed an in vitro study in which we treated tumor cells with exogenous TGF-β. This evidence concerns the gene TGFB1 and neoplasm.